LOGIN
OTA 2015: PTH bone-graft substitute vs. cancellous autograft for tibial plateau fractures
October 2015
OTA 2015: PTH bone-graft substitute vs. cancellous autograft for tibial plateau fractures
Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A
A Novel PTH-Based Bone Graft Substitute Demonstrates Noninferiority to Autograft in a Large Phase IIb Study of Tibial Plateau Fractures
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Synopsis
183 patients with a tibial plateau fracture were randomized to receive either a modified form of parathyroid hormone (PTH) in fibrin with hydroxapatite/tricalcium phosphate (HA/TCP) granules, or cancellous bone autograft following open reduction and internal fixation. Patients randomized to receive the bone graft substitute were treated with either a low-concentration (0.4mg/mL) or high-concentrat...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.